← back to search

Toyonori Tsuzuki

Aichi Medical University · JP
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, and Renal cell carcinoma treatment.
h-index
51
citations
10,628
works
526
NIH funding
primary concept
Medicine
email

Recent publications

Total Positive Margin Length as a Novel Prognostic Indicator After Radical Prostatectomy.
2026cited by 0position: contributordoi
Histopathological Heterogeneity in Pulmonary Hyalinizing Granulomas: A Case Report.
2026cited by 0position: contributordoi
A Case of Prostatic Mixed Germ Cell Tumor Showing Pagetoid Spread Into the Vas Deference in a Patient With Klinefelter Syndrome.
2026cited by 0position: contributordoi
Current Treatment Patterns and Outcomes of Sex Cord Stromal Tumor Patients in Japan.
2026cited by 0position: contributordoi
Predictive Factors for Gastrointestinal and Hepatic Adverse Events During 5-Aminolevulinic Acid-Guided Photodynamic Diagnosis in Bladder Cancer: Exploratory Analysis of the Phase III SPP2C102 Trial.
2026cited by 0position: contributordoi
The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate.
2026cited by 0position: contributordoi
Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of ALK Fusion Gene-Associated Renal Tumorigenesis.
2026cited by 0position: contributordoi
Supplementary Figure S6 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Figure S4 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Table S2 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Figure S3 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Data from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Table S3 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Table S2 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Table S1 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Figure S1 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Figure S5 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Figure S2 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Table S1 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Figure S6 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Supplementary Table S3 from Genetically Engineered Human iPS Cell-Derived Kidney Organoid Recapitulates an Early Stage of <i>ALK</i> Fusion Gene-Associated Renal Tumorigenesis
2026cited by 0position: contributordoi
Assessment and classification of sex cord‐stromal tumours of the testis: recommendations from the testicular sex cord‐stromal tumour (<scp>TESST</scp>) group, an Expert Panel of the Genitourinary Pathology Society (<scp>GUPS</scp>) and International Society of Urological Pathology (<scp>ISUP</scp>)
Histopathology 2025cited by 11position: middledoi
The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Urachal Neoplasms
The American Journal of Surgical Pathology 2025cited by 10position: middledoi
Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach
European Urology 2025cited by 10position: middledoi
Observer Variation in the Diagnosis of Testicular Sex Cord-Stromal Tumors by a Genitourinary Pathology Society and International Society of Urological Pathology Panel: Paving the Way for a New Classification
Modern Pathology 2025cited by 8position: middledoi
Assessment and classification of sex cord-stromal tumours of the testis: recommendations from the testicular sex cord-stromal tumour (TESST) group, an Expert Panel of the Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP).
2025cited by 8position: contributordoi
The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate
Histopathology 2025cited by 6position: middledoi
Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer
The American Journal of Surgical Pathology 2025cited by 6position: middledoi
The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Glandular Lesions of the Urinary Bladder
Advances in Anatomic Pathology 2025cited by 4position: middledoi
Unexpectedly high variability in determining tumour extent in prostatic biopsies: implications for active surveillance.
2025cited by 4position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 79 papers (2019–2026)Lars Egevad · Karolinska Institutet24 papers (2015–2023)Éva Compérat · University of Vienna16 papers (2019–2025)Daniel M. Berney · Queen Mary University of London16 papers (2020–2026)Hemamali Samaratunga · Western Sydney University15 papers (2019–2021)Kátia Ramos Moreira Leite · Universidade de São Paulo12 papers (2019–2023)Maria Rosaria Raspollini · Azienda Ospedaliero-Universitaria Careggi12 papers (2017–2025)Holger Moch · University of Zurich10 papers (2019–2022)Liang Cheng · State Key Laboratory of Chemical Engineering10 papers (2015–2021) · 10 papers (2019–2023)John R. Srigley · University of Toronto9 papers (2019–2022)Taishi Takahara · Springer Nature9 papers (2020–2025)George J. Netto · University of Pennsylvania8 papers (2022–2023)Mahul B. Amin · Ontario Institute for Cancer Research8 papers (2022–2022)Akira Satou · Nagoya University Hospital8 papers (2020–2026)Brett Delahunt · University of Otago8 papers (2019–2023)Mark A. Rubin · Praxis7 papers (2022–2022)Antonio López-Beltrán · Champalimaud Foundation7 papers (2016–2023)Gladell P. Paner · University of Chicago7 papers (2012–2020)Shingo Inaguma · Nagoya City University7 papers (2021–2024)